122
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Natural Antidiabetic Compound for the Therapeutic Management of Diabetes Mellitus and Its Drug Delivery System

, , , , &
Pages 266-279 | Received 24 Mar 2011, Accepted 04 Apr 2011, Published online: 11 Jul 2011
 

ABSTRACT

A single tablet dosage form containing the freeze-dried aqueous leaf extract of Vernonia amygdalina (AD1), suitable for use in the therapeutic management of diabetes mellitus, has been developed. The compaction characteristics of the extract were studied using the Heckel equation. The mechanical properties as well as disintegration and dissolution profile of the compacts were also assessed. The results showed that AD1 exhibited very low densification due to dye filling and addition of filler–binders contributed significantly to their subsequent densification. The tablets produced had good mechanical properties. Of the three filler–binders tested, tablets containing Avicel had the shortest disintegration time of about 5 min, while tablets without any filler–binder had the longest disintegration time of 50 min. Dissolution results (T90%) showed that tablets containing Avicel released 100% of the extract in less than 15 min proving to be the most suitable in acute diabetes. The order of dissolution is Avicel > maize starch > lactose > extract. It is concluded that incorporation of Avicel as a filler–binder in AD1 preparation produced tablets of suitable compaction properties and ensured adequate drug release for the therapeutic management of diabetes mellitus.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.